Article(id=1304388249217164129, tenantId=1146029695717560320, journalId=1302319053441957962, issueId=1304388157621948709, articleNumber=null, orderNo=null, doi=10.7501/j.issn.0253-2670.2026.15.015, pmid=null, cstr=null, oa=null, hot=0, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1769961600000, receivedDateStr=2026-02-02, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1788919992974, onlineDateStr=2026-09-09, pubDate=null, pubDateStr=null, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1788919992974, onlineIssueDateStr=2026-09-09, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1788919992974, creator=13701087609, updateTime=1788919992974, updator=13701087609, issue=Issue{id=1304388157621948709, tenantId=1146029695717560320, journalId=1302319053441957962, year='2026', volume='57', issue='15', pageStart='5789', pageEnd='6208', issueExtLink='null', onlineDate='null', pubDate='1786464000000', pubDateStr='2026-08-12', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=1, specialIssue=null, createTime=1788919971137, creator='13701087609', updateTime=1788923514106, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1304403017982300207, tenantId=1146029695717560320, journalId=1302319053441957962, issueId=1304388157621948709, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1304403017982300208, tenantId=1146029695717560320, journalId=1302319053441957962, issueId=1304388157621948709, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=5953, endPage=5966, ext={EN=ArticleExt(id=1304388249561097059, articleId=1304388249217164129, tenantId=1146029695717560320, journalId=1302319053441957962, language=EN, title=Effect and mechanism of Tianma Gouteng Yin in improving hypertensive vascular endothelial injury based on network pharmacology, molecular docking and experimental verification, columnId=null, journalTitle=Chinese Traditional and Herbal Drugs, columnName=null, runingTitle=null, highlight=null, articleAbstract=Objective To explore the potential active components, targets and molecular mechanism of Tianma Gouteng Yin (天麻钩藤饮) in improving vascular endothelial function in hypertension based on network pharmacology, molecular docking and experimental verification, and to clarify whether it exerts effects via phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt)/endothelial nitric oxide synthase (eNOS) signaling pathway. Methods Active components and targets of Tianma Gouteng Yin were screened through HERB and SwissTargetPrediction databases. Hypertension-related targets were obtained from OMIM and GeneCards databases. A protein-protein interaction (PPI) network was constructed, and Kyoto encyclopedia of genes and genomes (KEGG) pathway enrichment analysis was performed. Molecular docking was used to verify the binding affinity between core components and key targets in PI3K/Akt/eNOS pathway. Human umbilical vein endothelial cells (HUVECs) injured by angiotensin Ⅱ (Ang-Ⅱ) were used as the cell model. CCK-8, qRT-PCR, Western blotting, reactive oxygen species (ROS) and nitric oxide (NO) assays were applied to evaluate the effects of Tianma Gouteng Yin on cell viability, oxidative stress, inflammatory response and PI3K/Akt/eNOS pathway. Results Network pharmacology identified 228 active components and 969 overlapping hypertension-related targets of Tianma Gouteng Yin. Core targets included serine/threonine kinase 1 (AKT1) and PI3K family members [phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA), phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta (PIK3CB), etc.]. KEGG enrichment indicated that PI3K/Akt pathway was the key pathway. Molecular docking confirmed that core components such as kaempferol and apigenin showed strong binding affinity to PI3K/Akt pathway targets. The results of cell experiment showed that 25-100 mg/mL Tianma Gouteng Yin had no cytotoxicity in normal HUVECs, and dose-dependently attenuated Ang-Ⅱ-induced reduction in cell viability (P < 0.001), significantly inhibited the expressions of angiotensin-Ⅱ type 1 receptor (AT1R) and NADPH oxidase 4 (NOX4), as well as ROS production (P < 0.001), upregulated the levels of antioxidant enzymes including superoxide dismutase 1 (SOD1), catalase (CAT) and glutathione peroxidase 1 (GPX1) (P < 0.05, 0.01, 0.001), reduced the expressions of inflammatory factors including interleukin-6 (IL-6), IL-1β, tumor necrosis factor-α (TNF-α), intercellular adhesion molecule 1 (ICAM1) and vascular cell adhesion molecule 1 (VCAM1) (P < 0.01, 0.001), increased NO production and suppressed endothelin-1 (ET-1) expression (P < 0.01, 0.001), upregulated the protein expressions of p-PI3K, p-Akt and p-eNOS (P < 0.001). After administering the PI3K specific inhibitor Wortmannin, the activation effect of Tianma Gouteng Yin on PI3K/Akt pathway was significantly weakened, indicating that its endothelial protective effect depends on PI3K/Akt/eNOS signaling pathway. Conclusion Tianma Gouteng Yin may activate PI3K/Akt pathway through multi-target synergistic effects of core components such as kaempferol and apigenin, improve oxidative stress and inflammatory response, regulate the balance of NO and ET-1, and protect endothelial function in hypertension., authors=WANG Jie, SHOU Diwen, ZHOU Hengpu, authorsList=WANG Jie, SHOU Diwen, ZHOU Hengpu, authorCompany=null, correspAuthors=null, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1304388249489793890, articleId=1304388249217164129, tenantId=1146029695717560320, journalId=1302319053441957962, language=CN, title=基于网络药理学、分子对接和实验验证研究天麻钩藤饮改善高血压血管内皮损伤的作用及机制, columnId=1304140191707456168, journalTitle=中草药, columnName=药理与临床, runingTitle=null, highlight=null, articleAbstract=目的 基于网络药理学、分子对接和实验验证探究天麻钩藤饮改善高血压血管内皮功能的潜在活性成分、作用靶点及分子机制，明确其是否通过磷脂酰肌醇3-激酶（phosphatidylinositol 3-kinase，PI3K）/蛋白激酶B（protein kinase B，Akt）/内皮型一氧化氮合酶（endothelial nitric oxide synthase，eNOS）信号通路发挥作用。方法 通过HERB、SwissTargetPrediction数据库筛选天麻钩藤饮的活性成分及靶点，结合OMIM、GeneCards数据库获取高血压相关靶点，构建蛋白质-蛋白质相互作用（protein-protein interaction，PPI）网络并进行京都基因与基因组百科全书（Kyoto encyclopedia of genes and genomes，KEGG）通路富集分析；选取核心成分与PI3K/Akt/eNOS通路关键靶点进行分子对接验证。以血管紧张素-II（angiotensin-Ⅱ，Ang-Ⅱ）诱导的人脐静脉内皮细胞（human umbilical vein endothelial cells，HUVECs）损伤为模型，通过CCK-8、qRT-PCR、Western blotting、活性氧（reactive oxygen species，ROS）、一氧化氮（nitric oxide，NO）检测等实验验证天麻钩藤饮对细胞活力、氧化应激、炎症反应及PI3K/Akt/eNOS通路的影响。结果 网络药理学筛选出天麻钩藤饮228个活性成分及969个高血压相关交集靶点，核心靶点包括丝氨酸/苏氨酸蛋白激酶1（serine/threonine kinase 1，AKT1）、PI3K家族成员[磷脂酰肌醇-4,5-二磷酸3-激酶催化亚基α（phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha，PIK3CA）、磷脂酰肌醇-4,5-二磷酸3-激酶催化亚基β（phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta，PIK3CB）等]，KEGG富集分析显示PI3K/Akt信号通路为关键通路；分子对接证实山柰酚、芹菜素等核心成分与PI3K/Akt通路靶点结合亲和力强。细胞实验结果显示，25～100 mg/mL天麻钩藤饮对正常HUVECs无细胞毒性，可剂量相关性改善Ang-Ⅱ诱导的细胞活力降低（P ＜0.001）；显著抑制血管紧张素-II 1型受体（angiotensin-Ⅱ type 1 receptor，AT1R）、烟酰胺腺嘌呤二核苷酸磷酸氧化酶4（NADPH oxidase 4，NOX4）表达及ROS生成（P ＜0.001），上调超氧化物歧化酶1（superoxide dismutase 1，SOD1）、过氧化氢酶（catalase，CAT）、谷胱甘肽过氧化物酶1（glutathione peroxidase 1，GPX1）等抗氧化酶水平（P ＜0.05、0.01、0.001），下调白细胞介素-6（interleukin-6，IL-6）、IL-1β、肿瘤坏死因子-α（tumor necrosis factor-α，TNF-α）、细胞间黏附分子1（intercellular adhesion molecule 1，ICAM1）、血管细胞黏附分子1（vascular cell adhesion molecule 1，VCAM1）等炎性因子表达（P ＜0.01、0.001），增加NO生成并抑制内皮素-1（endothelin-1，ET-1）表达（P ＜0.01、0.001），上调p-PI3K、p-Akt、p-eNOS蛋白表达（P ＜0.001）；给予PI3K特异性抑制剂Wortmannin后，可显著削弱天麻钩藤饮对PI3K/Akt通路的激活效应，明确其内皮保护作用依赖于PI3K/Akt/eNOS信号通路。结论 天麻钩藤饮可能通过山柰酚、芹菜素等核心成分，多靶点协同激活PI3K/Akt通路，改善氧化应激与炎症反应，调节NO与ET-1的平衡，从而保护高血压状态下的血管内皮功能。, authors=王洁1 , 寿迪文1 , 周衡朴2 , authorsList=王洁, 寿迪文, 周衡朴, authorCompany=1 浙江中医药大学附属第一医院(浙江省中医院), 浙江 杭州 310006; + T cells between lymphoid and non-lymphoid organs and drives hypertension in a murine model [J]. Nat Commun, 2025, 16: 5818.
中草药
|药理与临床
2026
, 57
(15) :
5953
-5966
基于网络药理学、分子对接和实验验证研究天麻钩藤饮改善高血压血管内皮损伤的作用及机制
全屏
王洁1 , 寿迪文1 , 周衡朴2
作者信息
1 浙江中医药大学附属第一医院(浙江省中医院), 浙江 杭州 310006;
通讯作者:
周衡朴
作者简介:
王洁: 王洁（1997—），女，中药师，研究方向为中药药理与新产品开发。E-mail:1065238319@qq.com
Effect and mechanism of Tianma Gouteng Yin in improving hypertensive vascular endothelial injury based on network pharmacology, molecular docking and experimental verification
WANG Jie, SHOU Diwen, ZHOU Hengpu
Affiliations
doi: 10.7501/j.issn.0253-2670.2026.15.015
文章导航
目的 基于网络药理学、分子对接和实验验证探究天麻钩藤饮改善高血压血管内皮功能的潜在活性成分、作用靶点及分子机制，明确其是否通过磷脂酰肌醇3-激酶（phosphatidylinositol 3-kinase，PI3K）/蛋白激酶B（protein kinase B，Akt）/内皮型一氧化氮合酶（endothelial nitric oxide synthase，eNOS）信号通路发挥作用。方法 通过HERB、SwissTargetPrediction数据库筛选天麻钩藤饮的活性成分及靶点，结合OMIM、GeneCards数据库获取高血压相关靶点，构建蛋白质-蛋白质相互作用（protein-protein interaction，PPI）网络并进行京都基因与基因组百科全书（Kyoto encyclopedia of genes and genomes，KEGG）通路富集分析；选取核心成分与PI3K/Akt/eNOS通路关键靶点进行分子对接验证。以血管紧张素-II（angiotensin-Ⅱ，Ang-Ⅱ）诱导的人脐静脉内皮细胞（human umbilical vein endothelial cells，HUVECs）损伤为模型，通过CCK-8、qRT-PCR、Western blotting、活性氧（reactive oxygen species，ROS）、一氧化氮（nitric oxide，NO）检测等实验验证天麻钩藤饮对细胞活力、氧化应激、炎症反应及PI3K/Akt/eNOS通路的影响。结果 网络药理学筛选出天麻钩藤饮228个活性成分及969个高血压相关交集靶点，核心靶点包括丝氨酸/苏氨酸蛋白激酶1（serine/threonine kinase 1，AKT1）、PI3K家族成员[磷脂酰肌醇-4,5-二磷酸3-激酶催化亚基α（phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha，PIK3CA）、磷脂酰肌醇-4,5-二磷酸3-激酶催化亚基β（phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta，PIK3CB）等]，KEGG富集分析显示PI3K/Akt信号通路为关键通路；分子对接证实山柰酚、芹菜素等核心成分与PI3K/Akt通路靶点结合亲和力强。细胞实验结果显示，25～100 mg/mL天麻钩藤饮对正常HUVECs无细胞毒性，可剂量相关性改善Ang-Ⅱ诱导的细胞活力降低（P ＜0.001）；显著抑制血管紧张素-II 1型受体（angiotensin-Ⅱ type 1 receptor，AT1R）、烟酰胺腺嘌呤二核苷酸磷酸氧化酶4（NADPH oxidase 4，NOX4）表达及ROS生成（P ＜0.001），上调超氧化物歧化酶1（superoxide dismutase 1，SOD1）、过氧化氢酶（catalase，CAT）、谷胱甘肽过氧化物酶1（glutathione peroxidase 1，GPX1）等抗氧化酶水平（P ＜0.05、0.01、0.001），下调白细胞介素-6（interleukin-6，IL-6）、IL-1β、肿瘤坏死因子-α（tumor necrosis factor-α，TNF-α）、细胞间黏附分子1（intercellular adhesion molecule 1，ICAM1）、血管细胞黏附分子1（vascular cell adhesion molecule 1，VCAM1）等炎性因子表达（P ＜0.01、0.001），增加NO生成并抑制内皮素-1（endothelin-1，ET-1）表达（P ＜0.01、0.001），上调p-PI3K、p-Akt、p-eNOS蛋白表达（P ＜0.001）；给予PI3K特异性抑制剂Wortmannin后，可显著削弱天麻钩藤饮对PI3K/Akt通路的激活效应，明确其内皮保护作用依赖于PI3K/Akt/eNOS信号通路。结论 天麻钩藤饮可能通过山柰酚、芹菜素等核心成分，多靶点协同激活PI3K/Akt通路，改善氧化应激与炎症反应，调节NO与ET-1的平衡，从而保护高血压状态下的血管内皮功能。
天麻钩藤饮
/
高血压
/
血管内皮功能
/
氧化应激
/
炎症反应
/
PI3K/Akt/eNOS信号通路
/
网络药理学
/
山柰酚
/
芹菜素
Objective To explore the potential active components, targets and molecular mechanism of Tianma Gouteng Yin (天麻钩藤饮) in improving vascular endothelial function in hypertension based on network pharmacology, molecular docking and experimental verification, and to clarify whether it exerts effects via phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt)/endothelial nitric oxide synthase (eNOS) signaling pathway. Methods Active components and targets of Tianma Gouteng Yin were screened through HERB and SwissTargetPrediction databases. Hypertension-related targets were obtained from OMIM and GeneCards databases. A protein-protein interaction (PPI) network was constructed, and Kyoto encyclopedia of genes and genomes (KEGG) pathway enrichment analysis was performed. Molecular docking was used to verify the binding affinity between core components and key targets in PI3K/Akt/eNOS pathway. Human umbilical vein endothelial cells (HUVECs) injured by angiotensin Ⅱ (Ang-Ⅱ) were used as the cell model. CCK-8, qRT-PCR, Western blotting, reactive oxygen species (ROS) and nitric oxide (NO) assays were applied to evaluate the effects of Tianma Gouteng Yin on cell viability, oxidative stress, inflammatory response and PI3K/Akt/eNOS pathway. Results Network pharmacology identified 228 active components and 969 overlapping hypertension-related targets of Tianma Gouteng Yin. Core targets included serine/threonine kinase 1 (AKT1) and PI3K family members [phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA), phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta (PIK3CB), etc.]. KEGG enrichment indicated that PI3K/Akt pathway was the key pathway. Molecular docking confirmed that core components such as kaempferol and apigenin showed strong binding affinity to PI3K/Akt pathway targets. The results of cell experiment showed that 25-100 mg/mL Tianma Gouteng Yin had no cytotoxicity in normal HUVECs, and dose-dependently attenuated Ang-Ⅱ-induced reduction in cell viability (P < 0.001), significantly inhibited the expressions of angiotensin-Ⅱ type 1 receptor (AT1R) and NADPH oxidase 4 (NOX4), as well as ROS production (P < 0.001), upregulated the levels of antioxidant enzymes including superoxide dismutase 1 (SOD1), catalase (CAT) and glutathione peroxidase 1 (GPX1) (P < 0.05, 0.01, 0.001), reduced the expressions of inflammatory factors including interleukin-6 (IL-6), IL-1β, tumor necrosis factor-α (TNF-α), intercellular adhesion molecule 1 (ICAM1) and vascular cell adhesion molecule 1 (VCAM1) (P < 0.01, 0.001), increased NO production and suppressed endothelin-1 (ET-1) expression (P < 0.01, 0.001), upregulated the protein expressions of p-PI3K, p-Akt and p-eNOS (P < 0.001). After administering the PI3K specific inhibitor Wortmannin, the activation effect of Tianma Gouteng Yin on PI3K/Akt pathway was significantly weakened, indicating that its endothelial protective effect depends on PI3K/Akt/eNOS signaling pathway. Conclusion Tianma Gouteng Yin may activate PI3K/Akt pathway through multi-target synergistic effects of core components such as kaempferol and apigenin, improve oxidative stress and inflammatory response, regulate the balance of NO and ET-1, and protect endothelial function in hypertension.
Tianma Gouteng Yin
/
hypertension
/
vascular endothelial function
/
oxidative stress
/
inflammation
/
PI3K/Akt/eNOS signaling pathway
/
network pharmacology
/
kaempferol
/
2-apigenin
王洁, 寿迪文, 周衡朴.
基于网络药理学、分子对接和实验验证研究天麻钩藤饮改善高血压血管内皮损伤的作用及机制.
中草药,
2026
, 57
(15)
: 5953
-5966
.
DOI: 10.7501/j.issn.0253-2670.2026.15.015
WANG Jie, SHOU Diwen, ZHOU Hengpu.
Effect and mechanism of Tianma Gouteng Yin in improving hypertensive vascular endothelial injury based on network pharmacology, molecular docking and experimental verification[J].
Chinese Traditional and Herbal Drugs ,
2026
, 57
(15)
: 5953
-5966
.
DOI: 10.7501/j.issn.0253-2670.2026.15.015
参考文献
引证文献
Ohya Y, Sakima A, ARIMA H, et al. Key highlights of the Japanese Society of Hypertension Guidelines for the management of elevated blood pressure and hypertension 2025(JSH2025) [J]. Hypertens Res, 2025, 48(10): 2500-2511.+ T cells between lymphoid and non-lymphoid organs and drives hypertension in a murine model [J]. Nat Commun, 2025, 16: 5818.
2026年第57卷第15期
PDF下载
35
12
引用本文
BibTeX
文章信息
doi: 10.7501/j.issn.0253-2670.2026.15.015
接收时间：2026-02-02
首发时间：2026-09-09
https://castjournals.cast.org.cn/joweb/zcy/CN/10.7501/j.issn.0253-2670.2026.15.015
引用本文
BibTeX
2种不同金属材料的力学参数
科 属数 种数 占总种数比例 属 种数 占总种数比例 鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78 小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39 多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39 红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87 小菇属 Mycena 11 5.26 光柄菇属 Pluteus 5 2.39 红菇属 Russula 17 8.13 栓菌属 Trametes 5 2.39
关闭全屏
BibTeX
EndNote
RefWorks
TxT
PDF下载
全屏
35
12
关闭全屏
北京市海淀区学院南路86号
010-62199257（仅加盟咨询）
qkjq@cast.org.cn
